KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xylem (XYL) EBT Margin (2016 - 2025)

Xylem (XYL) has 15 years of EBT Margin data on record, last reported at 15.35% in Q4 2025.

  • For Q4 2025, EBT Margin fell 127.0% year-over-year to 15.35%; the TTM value through Dec 2025 reached 49.75%, up 2428.0%, while the annual FY2025 figure was 13.07%, 38.0% up from the prior year.
  • EBT Margin reached 15.35% in Q4 2025 per XYL's latest filing, up from 4950.0% in the prior quarter.
  • Across five years, EBT Margin topped out at 16.62% in Q4 2024 and bottomed at 4950.0% in Q3 2025.
  • Average EBT Margin over 5 years is 1101.63%, with a median of 270.81% recorded in 2021.
  • Peak YoY movement for EBT Margin: surged 151662bps in 2024, then tumbled -272214bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 633.33% in 2021, then soared by 102bps to 12.55% in 2022, then plummeted by -12052bps to 1500.0% in 2023, then surged by 101bps to 16.62% in 2024, then fell by -8bps to 15.35% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 15.35% in Q4 2025, 4950.0% in Q3 2025, and 3322.22% in Q2 2025.